Randomizované studie 2013
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results.
J Clin Oncol. 2013 Jan 1;31(1):65-72.
Více informací ZDE
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
J Clin Oncol. 2013 Jan 20;31(3):337-43.
Více informací ZDE
Radiation-free weekend rescued! Continuous accelerated irradiation of 7-days per week is equal to accelerated fractionation with concomitant boost of 7 fractions in 5-days per week: report on phase 3 clinical trial in head-and-neck cancer patients.
Int J Radiat Oncol Biol Phys. 2013 Mar 1;85(3):741-6.
Více informací ZDE
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
Ann Oncol. 2013 Apr;24(4):1099-104.
Více informací ZDE
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
Lancet Oncol. 2013 Mar;14(3):257-64.
Více informací ZDE
Radiotherapy for calcaneodynia. Results of a single center prospective randomized dose optimization trial.
Strahlenther Onkol. 2013 Apr;189(4):329-34.
Více informací ZDE
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320.
Int J Radiat Oncol Biol Phys. 2013 Apr 1;85(5):1312-8.
Více informací ZDE
Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial.
Lancet Oncol. 2013 May;14(6):516-24.
Více informací ZDE
Neoadjuvant treatment for unresectable rectal cancer: An interim analysis of a multicentre randomized study.
Radiother Oncol. 2013 May;107(2):171-7.
Více informací ZDE
Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer.
Radiother Oncol. 2013 May;107(2):123-8.
Více informací ZDE
A paired, double-blind, randomized comparison of a moisturizing durable barrier cream to 10% glycerine cream in the prophylactic management of postmastectomy irradiation skin care: trans Tasman Radiation Oncology Group (TROG) 04.01.
Int J Radiat Oncol Biol Phys. 2013 May 1;86(1):45-50.
Více informací ZDE
Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of China.
Cancer. 2013 Jun 15;119(12):2230-8.
Více informací ZDE
Comparison of concomitant boost radiotherapy against concurrent chemoradiation in locally advanced oropharyngeal cancers: A phase III randomised trial.
Radiother Oncol. 2013 Jun;107(3):317-24.
Více informací ZDE
Palliative brachytherapy with or without primary stent placement in patients with oesophageal cancer, a randomised phase III trial.
Radiother Oncol. 2013 Jun;107(3):428-33.
Více informací ZDE
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial.
Lancet Oncol. 2013 Jun;14(7):627-37.
Více informací ZDE
Alpha emitter radium-223 and survival in metastatic prostate cancer.
N Engl J Med. 2013 Jul 18;369(3):213-23.
Více informací ZDE
Decline in tested and self-reported cognitive functioning after prophylactic cranial irradiation for lung cancer: pooled secondary analysis of Radiation Therapy Oncology Group randomized trials 0212 and 0214.
Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):656-64.
Více informací ZDE
Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343.
J Clin Oncol. 2013 Jul 1;31(19):2382-7.
Více informací ZDE
Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial.
Eur J Cancer. 2013 Jul;49(10):2294-302.
Více informací ZDE
Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: Long-term results of the German CAO/ARO/AIO-94 phase III trial.
Radiother Oncol. 2013 Jul;108(1):48-54.
Více informací ZDE
Ten-year survival results of a randomized trial of irradiation of internal mammary nodes after mastectomy.
Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):860-6.
Více informací ZDE
Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer.
Acta Oncol. 2013 Oct;52(7):1535-42.
Více informací ZDE
A randomized clinical trial comparing prophylactic upper versus whole-neck irradiation in the treatment of patients with node-negative nasopharyngeal carcinoma.
Cancer. 2013 Sep 1;119(17):3170-6.
Více informací ZDE
Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions.
Radiother Oncol. 2013 Aug;108(2):203-8.
Více informací ZDE
Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK/01/004).
Int J Radiat Oncol Biol Phys. 2013 Oct 1;87(2):261-9.
Více informací ZDE
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Lancet Oncol. 2013 Oct;14(11):1086-94.
Více informací ZDE
HDR brachytherapy combined with interstitial hyperthermia in locally advanced cervical cancer patients initially treated with concomitant radiochemotherapy - a phase III study.
Radiother Oncol. 2013 Nov;109(2):194-9.
Více informací ZDE
Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation.
Radiother Oncol. 2013 Nov;109(2):297-302.
Více informací ZDE
Reduction of the dose to the elective neck in head and neck squamous cell carcinoma, a randomized clinical trial using intensity modulated radiotherapy (IMRT). Dosimetrical analysis and effect on acute toxicity.
Radiother Oncol. 2013 Nov;109(2):323-9.
Více informací ZDE
Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer.
J Clin Oncol. 2013 Nov 1;31(31):3860-8.
Více informací ZDE
Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):542-8.
Více informací ZDE
Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial.
J Clin Oncol. 2013 Nov 10;31(32):4054-9.
Více informací ZDE
A randomized controlled trial of Lorazepam to reduce liver motion in patients receiving upper abdominal radiation therapy.
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):881-7.
Více informací ZDE
Randomized controlled trial of intensity-modulated radiotherapy for early breast cancer: 5-year results confirm superior overall cosmesis.
J Clin Oncol. 2013 Dec 20;31(36):4488-95.
Více informací ZDE
